Healthcare Innovation July 12, 2024
Vertically integrated and concentrated market structure has allowed PBMs to profit at the expense of patients and independent pharmacists, interim report says
The Federal Trade Commission recently published an interim report on the impact that pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs. The Wall Street Journal reported that the FTC is preparing to sue the three largest PBMs — CVS Caremark, Express Scripts and OptumRx — over their tactics for negotiating prices for drugs. The FTC has conducted a two-year investigation into whether the PBMs steer patients away from less-expensive drugs.
The FTC said the interim staff report details how increasing vertical integration and concentration has enabled the six largest PBMs to manage...
Today's Sponsors
Today's Sponsor